Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study

BACKGROUND: Ovarian toxicity is a dreaded complication of cyclophosphamide (CYC). With the use of lower cumulative doses of intravenous CYC (modified NIH regimens) and availability of better markers of ovarian toxicity, the incidence of ovarian dysfunction needs reassessment. Lupus disease activity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Shefali Khanna, Jain, Siddharth, Bahl, Pooja, Potturi, Pragna, Rathi, Manish, Naidu, Shankar, Sachdeva, Naresh, Dhir, Varun, Jain, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429750/
https://www.ncbi.nlm.nih.gov/pubmed/32799907
http://dx.doi.org/10.1186/s13075-020-02292-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429750/
https://www.ncbi.nlm.nih.gov/pubmed/32799907
http://dx.doi.org/10.1186/s13075-020-02292-y

Ejemplares similares